首页> 美国卫生研究院文献>World Journal of Gastroenterology >Primary intestinal non-Hodgkin's lymphoma: A clinicopathologic analysis of 81 patients
【2h】

Primary intestinal non-Hodgkin's lymphoma: A clinicopathologic analysis of 81 patients

机译:原发性肠非霍奇金淋巴瘤:81例患者的临床病理分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

AIM: To analyze the clinicopathologic features and the prognosis of primary intestinal lymphoma.METHODS: Patients were included in the study based on standard diagnostic criteria for primary gastrointestinal lymphoma, and were treated at Sun Yat-sen University Cancer Centre between 1993 and 2008.RESULTS: The study comprised 81 adults. The most common site was the ileocaecal region. Twenty-two point two percent patients had low-grade B-cell lymphoma. Fifty-one point nine percent patients had high-grade B-cell lymphoma and 25.9% patients had T-cell lymphoma. Most patients had localized disease. There were more patients and more early stage diseases in the latter period, and the origin sites changed. The majority of patients received the combined treatment, and about 20% patients only received nonsurgical therapy. The wverall survival and event-free survival rates after 5 years were 71.6% and 60.9% respectively. The multivariate analysis revealed that small intestine and ileocaecal region localization, B-cell phenotype, and normal lactate dehydrogenase were independent prognostic factors for better patient survival. Surgery based treatment did not improve the survival rate.CONCLUSION: Refined stratification of the patients according to the prognostic variables may allow individualized treatment. Conservative treatment may be an optimal therapeutic modality for selected patients.
机译:目的:分析原发性肠淋巴瘤的临床病理特征和预后。方法:根据标准的原发性胃肠道淋巴瘤诊断标准对患者进行研究,并于1993年至2008年在中山大学癌症中心接受治疗。 :该研究包括81位成人。最常见的部位是回盲区。 22%的百分之二的患者患有低度B细胞淋巴瘤。 51%的患者有51点患有高级别B细胞淋巴瘤,而25.9%的患者患有T细胞淋巴瘤。大多数患者患有局部疾病。晚期患者较多,早期疾病较多,起源部位发生了变化。大多数患者接受联合治疗,大约20%的患者仅接受非手术治疗。 5年后的全部生存率和无事件生存率分别为71.6%和60.9%。多元分析表明,小肠和回盲区的定位,B细胞表型和正常的乳酸脱氢酶是改善患者生存率的独立预后因素。手术治疗不能提高患者的生存率。结论:根据预后因素对患者进行精细分层可以允许个体化治疗。保守治疗可能是某些患者的最佳治疗方式。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号